App

China to complete phase 2 clinical trials of COVID-19 vaccines beginning in July: official
Updated: May 15, 2020 19:26 Xinhua

BEIJING — The second phase of clinical trials for COVID-19 vaccines is expected to be completed successively beginning in July, and no major adverse reactions from the trials had been reported so far, a Chinese official said on May 15.

The vaccines undergoing clinical trials include one adenovirus vector vaccine and four inactivated vaccines fast-tracked by China's National Medical Products Administration, Zeng Yixin, a senior official with the National Health Commission, said at a news conference.

A total of 2,036 volunteer participants have been inoculated for the second phase of clinical trials and researchers are assessing whether or not the vaccines are safe and effective, according to Zeng.

Copyright© www.gov.cn | About us | Contact us

Website Identification Code bm01000001 Registration Number: 05070218

All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to www.gov.cn.

Without written authorization from www.gov.cn, such content shall not be republished or used in any form.

Mobile

Desktop

Copyright© www.gov.cn | Contact us

Website Identification Code bm01000001

Registration Number: 05070218